
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease”, Clin Gastroenterol Hepatol, vol. 9, pp. 875-80, 2011.
, “Chronic statin therapy and the risk of colorectal cancer”, Pharmacoepidemiol Drug Saf, vol. 17, pp. 869-76, 2008.
, “Immunosuppressant medications and mortality in inflammatory bowel disease”, Am J Gastroenterol, vol. 103, pp. 1428-35; quiz 1436, 2008.
, “Chronic proton pump inhibitor therapy and the risk of colorectal cancer”, Gastroenterology, vol. 133, pp. 748-54, 2007.
, “Risk for active tuberculosis in inflammatory bowel disease patients”, Clin Gastroenterol Hepatol, vol. 5, pp. 1070-5, 2007.
, “Risk of colorectal cancer in women with a prior diagnosis of gynecologic malignancy”, J Clin Gastroenterol, vol. 41, pp. 291-6, 2007.
, “The risk of mortality in patients with psoriasis: results from a population-based study”, Arch Dermatol, vol. 143, pp. 1493-9, 2007.
, “Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the General Practice Research Database”, Ann Rheum Dis, vol. 65, pp. 1074-9, 2006.
, “Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease”, Clin Gastroenterol Hepatol, vol. 4, pp. 1483-90, 2006.
, “Antibiotic use and the risk of flare of inflammatory bowel disease”, Clin Gastroenterol Hepatol, vol. 3, pp. 459-65, 2005.
, “Increased risk for demyelinating diseases in patients with inflammatory bowel disease”, Gastroenterology, vol. 129, pp. 819-26, 2005.
, “The relationship between time since registration and measured incidence rates in the General Practice Research Database”, Pharmacoepidemiol Drug Saf, vol. 14, pp. 443-51, 2005.
, “Type 2 diabetes mellitus and the risk of colorectal cancer”, Clin Gastroenterol Hepatol, vol. 3, pp. 587-94, 2005.
, “Agreement between GPRD smoking data: a survey of general practitioners and a population-based survey”, Pharmacoepidemiol Drug Saf, vol. 13, pp. 437-41, 2004.
, “Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients”, Gastroenterology, vol. 127, pp. 1044-50, 2004.
, “Seasonal variation in flares of inflammatory bowel disease”, Gastroenterology, vol. 126, pp. 665-73, 2004.
, “Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease”, Pharmacoepidemiol Drug Saf, vol. 11, pp. 211-8, 2002.
, “Inflammatory bowel disease associated with immune thrombocytopenic purpura in children”, J Pediatr Gastroenterol Nutr, vol. 33, pp. 582-7, 2001.
, “Inflammatory bowel disease is not associated with an increased risk of lymphoma”, Gastroenterology, vol. 121, pp. 1080-7, 2001.
,